Literature DB >> 28363424

Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.

Haiyun Yang1, Ming Xu2, Xiufang Chi3, Qun Yan4, Yadong Wang4, Wen Xu4, Kangmin Zhuang4, Aimin Li5, Side Liu6.   

Abstract

AIM: Protein kinase D (PKD) acts as a key mediator in several cancer development signaling pathways. The aim of this study was to investigate the clinical significance and prognostic value of PKD3 expression in hepatocellular carcinoma (HCC) patients after hepatectomy.
METHODS: PKD3 mRNA and protein expression levels in tumor and matched non-tumoral (NT) tissues, HCC cell lines were evaluated by quantitative PCR (qRT-PCR), western blotting and immunohistochemical staining (IHC). Additionally, PKD3 mRNA expression in HCC tissues correlated with clinicopathological characteristics and survival.
RESULTS: PKD3 mRNA and protein expression was elevated in HCC tissues and HCC cell lines. Our data also showed that in HCC patients after resection, a high-expression of PKD3 mRNA and protein significantly correlated with multiple tumor nodules (P=0.009, P=0.020, respectively), poor tumor differentiation (P=0.001, P=0.004, respectively), high serum AFP level (P=0.005, P=0.002, respectively), vascular invasion (P=0.006, P=0.009, respectively) and advanced AJCC stage (P=0.001, P=0.022, respectively). A Kaplan-Meier analysis indicated that an elevated PKD3 mRNA expression correlated with shorter overall survival (OS) (P<0.001) and disease-free survival (DFS) (P=0.008). Moreover, multivariate analysis showed that a high-expression of PKD3 was an independent prognostic factor for three-year overall survival rate.
CONCLUSIONS: Our findings suggest that abnormal PKD3 expression might contribute to HCC progression. Furthermore, high PKD3 expression predicts a poor prognosis in HCC patients after hepatectomy.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28363424     DOI: 10.1016/j.clinre.2017.02.005

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  3 in total

Review 1.  The oncogenic role of protein kinase D3 in cancer.

Authors:  Yan Liu; Hang Song; Yehui Zhou; Xinxing Ma; Jing Xu; Zhenghong Yu; Liming Chen
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

2.  Deletion of Protein Kinase D3 Promotes Liver Fibrosis in Mice.

Authors:  Shuya Zhang; Huan Liu; Meimei Yin; Xiuying Pei; Angelika Hausser; Eri Ishikawa; Sho Yamasaki; Zheng Gen Jin
Journal:  Hepatology       Date:  2020-09-28       Impact factor: 17.298

3.  A phosphoproteomic approach reveals that PKD3 controls PKA-mediated glucose and tyrosine metabolism.

Authors:  Angel Loza-Valdes; Alexander E Mayer; Toufic Kassouf; Jonathan Trujillo-Viera; Werner Schmitz; Filip Dziaczkowski; Michael Leitges; Andreas Schlosser; Grzegorz Sumara
Journal:  Life Sci Alliance       Date:  2021-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.